The Current Ratio as of November 2024 (TTM) for Intercept Pharmaceuticals, Inc. (ICPT) is 4.22

According to Intercept Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.22. This represents a change of 47.41% compared to the average of 2.86 of the last 4 quarters.

Intercept Pharmaceuticals, Inc. (ICPT) Historical Current Ratio (quarterly & annually)

How has ICPT Current Ratio performed in the past?

The mean historical Current Ratio of Intercept Pharmaceuticals, Inc. over the last ten years is 7.63. The current 4.22 Current Ratio has changed 5.43% with respect to the historical average. Over the past ten years (40 quarters), ICPT's Current Ratio was at its highest in in the June 2015 quarter at 31.15. The Current Ratio was at its lowest in in the March 2014 quarter at 0.48.

Intercept Pharmaceuticals, Inc. (ICPT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Intercept Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Intercept Pharmaceuticals, Inc. (ICPT) Average Current Ratio

How has ICPT Current Ratio performed in the past?

The current Current Ratio of Intercept Pharmaceuticals, Inc. (ICPT) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Intercept Pharmaceuticals, Inc. (ICPT) Current Ratio vs. Peers

How is ICPT’s Current Ratio compared to its peers?

Intercept Pharmaceuticals, Inc.’s Current Ratio is less than Viking Therapeutics, Inc. (36.47), less than Terns Pharmaceuticals, Inc. (32.99), less than Akero Therapeutics, Inc. (17.25), less than Reata Pharmaceuticals, Inc. (6.75), less than Madrigal Pharmaceuticals, Inc. (5.98), less than TG Therapeutics, Inc. (4.59), greater than Hepion Pharmaceuticals, Inc. (1.30), greater than PTC Therapeutics, Inc. (2.10), less than Krystal Biotech, Inc. (7.97), less than AVROBIO, Inc. (26.17), less than CohBar, Inc. (15.69), greater than Ocean Biomedical, Inc. (0.03), less than Enveric Biosciences, Inc. (5.17), less than Elevation Oncology, Inc. (17.77), greater than Sarepta Therapeutics, Inc. (3.84), less than Mirati Therapeutics, Inc. (7.54),

Build a custom stock screener for Intercept Pharmaceuticals, Inc. (ICPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Intercept Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Intercept Pharmaceuticals, Inc. (ICPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Intercept Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.